The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function

Published:2015-06-04 Issue:6 Volume:10 Page:e0128897
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Heine Annkristin,Held Stefanie Andrea Erika,Daecke Solveig Nora,Riethausen Kati,Kotthoff Philipp,Flores Chrystel,Kurts Christian,Brossart Peter

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference20 articles.

1. Immunotherapy in renal cell carcinoma;A Heine;Immunotherapy,2009

2. Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patients;SM Rittig;Mol Ther,2011

3. Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival;S Walter;Nat Med,2012

4. Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses;MM Hipp;Blood,2008

5. Reduced immunosuppressive properties of axitinib in comparison with other tyrosine kinase inhibitors;F Stehle;J Biol Chem,2013

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct and indirect regulation of the tumor immune microenvironment by VEGF;Journal of Leukocyte Biology;2022-04-25

2. Drug delivery strategies in maximizing anti-angiogenesis and anti-tumor immunity;Advanced Drug Delivery Reviews;2021-12

3. Evaluation of β-Catenin Inhibition of Axitinib and Nitazoxanide in Human Monocyte-Derived Dendritic Cells;Biomedicines;2021-08-03

4. The Combination of Immune Checkpoint Blockade and Angiogenesis Inhibitors in the Treatment of Advanced Non-Small Cell Lung Cancer;Frontiers in Immunology;2021-06-02

5. Postponing tumor onset and tumor progression can be achieved by alteration of local tumor immunity;Cancer Cell International;2021-02-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3